Incidence and case fatality rate of COVID-19 in patients with active epilepsy
Top Cited Papers
- 8 September 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 95 (10), e1417-e1425
- https://doi.org/10.1212/wnl.0000000000010033
Abstract
Objective This article estimates the incidence and fatality of coronavirus disease 2019 (COVID-19) and identifies potential risk factors for fatality in patients with active epilepsy. Methods This is a cross-sectional observational study of patients with active epilepsy and COVID-19. A control group was used to compare the cumulative incidence and case-fatality rate (CFR). The main outcomes of the study were cumulative incidence, defined as number of patients with active epilepsy and COVID-19 admitted to an emergency department divided by the total number of patients with epilepsy at risk, and CFR based on the number of deaths during the enrollment period. Multiple logistic regression analysis was performed to investigate risk factors for fatality in patients with active epilepsy. Results Of the 1,537 patients who fulfilled the inclusion criteria, 21 (1.3%) had active epilepsy. The cumulative incidence (95% confidence interval [CI]) of COVID-19 in patients with epilepsy was higher (1.2% [0.6–2.4]) compared to the population without epilepsy (0.5% [0.5–0.5]). In reverse transcription PCR–positive patients, there were no significant differences in CFR in patients with active epilepsy compared to patients without epilepsy (33.3% vs 8.3%; p = 0.266). Of the 21 patients with active epilepsy, 5 (23%) died. In multivariate analysis, the factor associated with fatality in patients with active epilepsy was hypertension (odds ratio [OR] 2.8 [95% CI 1.3–21.6]). In another model, age (OR 1.0 [95% CI 1.0–1.1]) and epilepsy (OR 5.1 [95% CI 1.3–24.0]) were associated with fatality during hospitalization. Conclusion COVID-19 cumulative incidence was higher in patients with active epilepsy. Epilepsy was associated with fatality during hospitalization. Hypertension was associated with fatality in patients with epilepsy.Keywords
This publication has 23 references indexed in Scilit:
- Tackling Epilepsy With High-definition Precision MedicineJAMA Neurology, 2019
- Epilepsy is a neurological and a systemic disorderEpilepsy & Behavior, 2018
- Do antiepileptic drugs increase the risk of infectious diseases? A meta‐analysis of placebo‐controlled studiesBritish Journal of Clinical Pharmacology, 2017
- Prevalence and incidence of epilepsyNeurology, 2017
- Adult Prevalence of Epilepsy in Spain: EPIBERIA, a Population-Based StudyThe Scientific World Journal, 2015
- Comorbidities of epilepsy: current concepts and future perspectivesThe Lancet Neurology, 2015
- ILAE Official Report: A practical clinical definition of epilepsyEpilepsia, 2014
- The somatic comorbidity of epilepsy: A weighty but often unrecognized burdenEpilepsia, 2012
- The Epidemiology of the Comorbidity of Epilepsy in the General PopulationEpilepsia, 2004
- Guidelines for Epidemiologic Studies on EpilepsyEpilepsia, 1993